scPharmaceuticals Inc. (SCPH) financial statements (2022 and earlier)

Company profile

Business Address 2400 DISTRICT AVENUE
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75,278105,09572,62489,478
Cash and cash equivalents74,26871,81972,62489,478
Short-term investments1,01033,276  
Restricted cash and investments182   
Receivables  310479
Prepaid expense2,7912,6102,6191,757
Other current assets2412194179
Total current assets:78,275107,82675,64791,893
Noncurrent Assets
Operating lease, right-of-use asset4108151,179
Property, plant and equipment6993127164
Restricted cash and investments 182182182
Other undisclosed noncurrent assets2831321481,516
Total noncurrent assets:7621,2221,6361,862
TOTAL ASSETS:79,037109,04877,28393,755
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,5396,4534,8303,509
Accounts payable5441,6661,142587
Accrued liabilities3,9954,7873,6882,922
Debt9,8052,4084072,811
Other liabilities26   
Other undisclosed current liabilities476460 353
Total current liabilities:14,8469,3215,2376,673
Noncurrent Liabilities
Long-term debt and lease obligation7,35417,33819,8586,826
Long-term debt, excluding current maturities7,35416,85818,9156,826
Operating lease, liability 480943
Liabilities, other than long-term debt367219823159
Other liabilities36721958159
Derivative instruments and hedges, liabilities  765 
Other undisclosed noncurrent liabilities   1,353
Total noncurrent liabilities:7,72117,55720,6818,338
Total liabilities:22,56726,87825,91815,011
Stockholders' equity
Stockholders' equity attributable to parent56,47082,17051,36578,744
Common stock3322
Additional paid in capital246,166243,830180,818175,201
Accumulated other comprehensive income (loss)(1)1  
Accumulated deficit(189,698)(161,664)(129,455)(96,459)
Total stockholders' equity:56,47082,17051,36578,744
TOTAL LIABILITIES AND EQUITY:79,037109,04877,28393,755

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues
(Sublease Income)
515156 
Gross profit:515156 
Operating expenses(25,823)(29,933)(32,905)(29,667)
Other undisclosed operating loss(51)(51)(56) 
Operating loss:(25,823)(29,933)(32,905)(29,667)
Nonoperating income3643111,6761,656
Investment income, nonoperating493151,6601,712
Other nonoperating income (expense)315(4)16(56)
Interest and debt expense(2,575)(2,587)(1,767)(1,432)
Net loss available to common stockholders, diluted:(28,034)(32,209)(32,996)(29,443)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(28,034)(32,209)(32,996)(29,443)
Comprehensive loss:(28,034)(32,209)(32,996)(29,443)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)1  
Comprehensive loss, net of tax, attributable to parent:(28,036)(32,208)(32,996)(29,443)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: